Luciana Bonnot

Bringing Brain Science
to Healthcare Innovation

I’m Luciana Bonnot, neuroscientist and consultant — I help health tech and medtech teams make informed decisions about brain biomarkers — aligning evidence, trials, and regulatory expectations before costly mistakes happen.

Schedule a Call
Luciana Bonnot portrait

About

With a PhD in Neuroscience and 20+ years across research and hospital-based innovation, I help healthcare and medtech teams turn brain science into decision-ready clinical evidence.

I advise organizations on how to design and evaluate neuroimaging and brain biomarkers so they are scientifically credible and fit for clinical use.

Based in France, I work internationally in English, French, and Portuguese.

Why Work With Me?

Neuroimaging decision-making

I help teams make clear, defensible decisions about what imaging data can and cannot support in a clinical context.

Early risk reduction

I intervene before protocol lock to clarify feasibility, evidence level, and downstream implications.

Real-world trial awareness

My experience spans research and hospital-based innovation, where imaging, timelines, and constraints must align.

Consulting Expertise

I guide brain-focused health innovations from concept to scientific readiness, clarifying neuroimaging strategy and evidence requirements early.

Target with arrow icon

Neuroimaging feasibility & evidence readiness

Assessing validation pathways, risks, and operational constraints before protocols or pilots are launched.

RWE

Clinical and real-world imaging evidence

Interpreting neuroimaging-derived endpoints and metrics to inform trial and real-world decisions.

Brain icon

Neuroimaging strategy & context of use

Clarifying whether neuroimaging is appropriate, what role it should play, and what claims it can realistically support.

Papers

Practical tools and documentation I share publicly. Reuse is encouraged with attribution (CC BY-NC 4.0).

Digital neuroimaging biomarker readiness map

From imaging-derived signals to trial-ready endpoints in CNS drug development.

Format: PDF

License: CC BY-NC 4.0

Year: 2026

If you use or adapt figures internally, please cite the document and keep attribution visible.

What you can expect

Feedback from collaborators.

“Rapid understanding of complex topics”

“Solid evidence, without the academic fog”

Let’s Work Together

Early, clear decisions around neuroimaging and brain biomarkers.

Share your idea — I’ll reply within 48 hours.

Confidentiality assured. NDA available if needed.